hit counter
BioLife Solutions, Inc. (BLFS) Stock News Sentiment & Price - Sentifly
BLFS - Sentifly


Profile

Watchlist

Your watchlist is empty. Go add some tickers to it!



BioLife Solutions, Inc. (BLFS)

USA
Medical Instruments & Supplies
NASDAQ
BLFS Price and Sentiment
1MO
1D
Positive, Negative
Loading chart...
BLFS Latest news
The Motley Fool
Positive
Have $500? This Under-the-Radar Stock Could Make You Richer From the Biotech Boom
2021-10-15 06:50

This company is preserving biological material and can help your portfolio grow.

PRNewsWire
Neutral
BioLife Solutions Leverages Expanded Bioproduction Tools and Services Portfolio in Multipoint Engagement with Leading CAR T-Cell Developer
2021-10-04 08:00

BOTHELL, Wash., Oct. 4, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced a broad engagement with a leading cell therapy developer, wherein BioLife's CryoStor freeze media, evo cold chain management platform and SciSafe storage services with Stirling UltraCold freezers are all being utilized by this top 10 largest global pharmaceutical company to support the anticipated regulatory approval and commercial launch of a new CAR T-cell therapy.

Benzinga
Positive
Notable Biolife Solutions Insider Trades $971 Thousand In Company Stock
2021-09-23 11:01

Aby Mathew, Exec VP And Chief Scientific Off at Biolife Solutions (NASDAQ:BLFS), made a large buy and sell of company shares on September 22, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission states that Aby Mathew exercised options to purchase 20,000 Biolife Solutions shares at a price of $1.64 per share for a total of $32,800 on September 22.

PRNewsWire
Neutral
BioLife Solutions Appoints Joydeep Goswami, MBA, PhD to Board of Directors
2021-09-20 08:00

BOTHELL, Wash., Sept. 20, 2021 /PRNewswire/ -- BioLife Solutions , Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced that Joydeep Goswami, Chief Strategy and Corporate Development Officer at Illumina, will join its board of directors on October 1, 2021.

PRNewsWire
Neutral
BioLife Solutions Announces CFO Retirement
2021-09-15 08:00

BOTHELL, Wash., Sept. 15, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced that Roderick de Greef, Chief Financial Officer, plans to retire on December 31, 2021 after a distinguished career with the Company.

The Motley Fool
Positive
Why Shares in BioLife Solutions Jumped 24.4% in August
2021-09-07 18:10

The company, which specializes in cold-storage solutions for biotechs, had a hot month.

PRNewsWire
Neutral
BioLife Solutions Files Form S-3 Registration Statement to Register Shares from Completed Acquisitions
2021-09-01 17:36

BOTHELL, Wash., Sept. 1, 2021 /PRNewswire/ -- BioLife Solutions , Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, announces that it has filed a registration statement on Form S-3 with the Securities and Exchange Commission ("SEC") to register approximately 10.7 million shares of restricted common stock held by stockholders of previously acquired companies Global Cooling, Inc. (operating as Stirling Ultracold), SciSafe Holdings, Inc. and Sexton Biotechnologies, Inc., as well as certain shares held by Casdin Capital.

PRNewsWire
Neutral
BioLife Solutions Closes Acquisition of Sexton Biotechnologies
2021-09-01 09:08

BOTHELL, Wash., Sept. 1, 2021 /PRNewswire/ --  BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced that it has closed its acquisition of Sexton Biotechnologies.

Pulse2
Positive
BLFS Stock: 19.62% Increase Explanation
2021-08-25 21:05

The stock price of BioLife Solutions Inc (NASDAQ: BLFS) increased by 19.62% today. This is why it happened.

The Motley Fool
Neutral
2 Little-Known Nasdaq Stocks Making Big Moves Wednesday
2021-08-25 13:10

Don't let these companies fly under your radar.

Loading more news...